231 related articles for article (PubMed ID: 20947116)
21. Genotypic coreceptor analysis.
Sierra S; Kaiser R; Thielen A; Lengauer T
Eur J Med Res; 2007 Oct; 12(9):453-62. PubMed ID: 17933727
[TBL] [Abstract][Full Text] [Related]
22. Nonproductive human immunodeficiency virus type 1 infection of human fetal astrocytes: independence from CD4 and major chemokine receptors.
Sabri F; Tresoldi E; Di Stefano M; Polo S; Monaco MC; Verani A; Fiore JR; Lusso P; Major E; Chiodi F; Scarlatti G
Virology; 1999 Nov; 264(2):370-84. PubMed ID: 10562499
[TBL] [Abstract][Full Text] [Related]
23. HIV biological variability unveiled: frequent isolations and chimeric receptors reveal unprecedented variation of coreceptor use.
Karlsson I; Antonsson L; Shi Y; Karlsson A; Albert J; Leitner T; Olde B; Owman C; Fenyö EM
AIDS; 2003 Dec; 17(18):2561-9. PubMed ID: 14685050
[TBL] [Abstract][Full Text] [Related]
24. The promiscuous CC chemokine receptor D6 is a functional coreceptor for primary isolates of human immunodeficiency virus type 1 (HIV-1) and HIV-2 on astrocytes.
Neil SJ; Aasa-Chapman MM; Clapham PR; Nibbs RJ; McKnight A; Weiss RA
J Virol; 2005 Aug; 79(15):9618-24. PubMed ID: 16014924
[TBL] [Abstract][Full Text] [Related]
25. Differences in chemokine coreceptor usage between genetic subtypes of HIV-1.
Tscherning C; Alaeus A; Fredriksson R; Björndal A; Deng H; Littman DR; Fenyö EM; Albert J
Virology; 1998 Feb; 241(2):181-8. PubMed ID: 9499793
[TBL] [Abstract][Full Text] [Related]
26. Epidemiology and predictive factors for chemokine receptor use in HIV-1 infection.
Moyle GJ; Wildfire A; Mandalia S; Mayer H; Goodrich J; Whitcomb J; Gazzard BG
J Infect Dis; 2005 Mar; 191(6):866-72. PubMed ID: 15717260
[TBL] [Abstract][Full Text] [Related]
27. Use of GPR1, GPR15, and STRL33 as coreceptors by diverse human immunodeficiency virus type 1 and simian immunodeficiency virus envelope proteins.
Edinger AL; Hoffman TL; Sharron M; Lee B; O'Dowd B; Doms RW
Virology; 1998 Sep; 249(2):367-78. PubMed ID: 9791028
[TBL] [Abstract][Full Text] [Related]
28. Chemokine (C-C motif) receptor 5-using envelopes predominate in dual/mixed-tropic HIV from the plasma of drug-naive individuals.
Irlbeck DM; Amrine-Madsen H; Kitrinos KM; Labranche CC; Demarest JF
AIDS; 2008 Jul; 22(12):1425-31. PubMed ID: 18614865
[TBL] [Abstract][Full Text] [Related]
29. Pouncing on the chemokine receptor Chimera.
Mascolini M
J Int Assoc Physicians AIDS Care; 1997 Aug; 3(8):13-24. PubMed ID: 11364629
[TBL] [Abstract][Full Text] [Related]
30. Coreceptor usage of primary human immunodeficiency virus type 1 isolates varies according to biological phenotype.
Björndal A; Deng H; Jansson M; Fiore JR; Colognesi C; Karlsson A; Albert J; Scarlatti G; Littman DR; Fenyö EM
J Virol; 1997 Oct; 71(10):7478-87. PubMed ID: 9311827
[TBL] [Abstract][Full Text] [Related]
31. HIV-1 coreceptors and their inhibitors.
Ray N; Doms RW
Curr Top Microbiol Immunol; 2006; 303():97-120. PubMed ID: 16570858
[TBL] [Abstract][Full Text] [Related]
32. Dual-tropic HIV type 1 isolates vary dramatically in their utilization of CCR5 and CXCR4 coreceptors.
Toma J; Whitcomb JM; Petropoulos CJ; Huang W
AIDS; 2010 Sep; 24(14):2181-6. PubMed ID: 20639728
[TBL] [Abstract][Full Text] [Related]
33. Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease.
Berger EA; Murphy PM; Farber JM
Annu Rev Immunol; 1999; 17():657-700. PubMed ID: 10358771
[TBL] [Abstract][Full Text] [Related]
34. Identification of a subset of human immunodeficiency virus type 1 (HIV-1), HIV-2, and simian immunodeficiency virus strains able to exploit an alternative coreceptor on untransformed human brain and lymphoid cells.
Willey SJ; Reeves JD; Hudson R; Miyake K; Dejucq N; Schols D; De Clercq E; Bell J; McKnight A; Clapham PR
J Virol; 2003 Jun; 77(11):6138-52. PubMed ID: 12743271
[TBL] [Abstract][Full Text] [Related]
35. Use of coreceptors other than CCR5 by non-syncytium-inducing adult and pediatric isolates of human immunodeficiency virus type 1 is rare in vitro.
Zhang YJ; Dragic T; Cao Y; Kostrikis L; Kwon DS; Littman DR; KewalRamani VN; Moore JP
J Virol; 1998 Nov; 72(11):9337-44. PubMed ID: 9765485
[TBL] [Abstract][Full Text] [Related]
36. CCR5, GPR15, and CXCR6 are major coreceptors of human immunodeficiency virus type 2 variants isolated from individuals with and without plasma viremia.
Blaak H; Boers PH; Gruters RA; Schuitemaker H; van der Ende ME; Osterhaus AD
J Virol; 2005 Feb; 79(3):1686-700. PubMed ID: 15650194
[TBL] [Abstract][Full Text] [Related]
37. V3 recombinants indicate a central role for CCR5 as a coreceptor in tissue infection by human immunodeficiency virus type 1.
Chan SY; Speck RF; Power C; Gaffen SL; Chesebro B; Goldsmith MA
J Virol; 1999 Mar; 73(3):2350-8. PubMed ID: 9971818
[TBL] [Abstract][Full Text] [Related]
38. Use of inhibitors to evaluate coreceptor usage by simian and simian/human immunodeficiency viruses and human immunodeficiency virus type 2 in primary cells.
Zhang Y; Lou B; Lal RB; Gettie A; Marx PA; Moore JP
J Virol; 2000 Aug; 74(15):6893-910. PubMed ID: 10888629
[TBL] [Abstract][Full Text] [Related]
39. Evolution of human immunodeficiency virus type 2 coreceptor usage, autologous neutralization, envelope sequence and glycosylation.
Shi Y; Brandin E; Vincic E; Jansson M; Blaxhult A; Gyllensten K; Moberg L; Broström C; Fenyö EM; Albert J
J Gen Virol; 2005 Dec; 86(Pt 12):3385-3396. PubMed ID: 16298986
[TBL] [Abstract][Full Text] [Related]
40. The CCR5 and CXCR4 coreceptors are both used by human immunodeficiency virus type 1 primary isolates from subtype C.
Cilliers T; Nhlapo J; Coetzer M; Orlovic D; Ketas T; Olson WC; Moore JP; Trkola A; Morris L
J Virol; 2003 Apr; 77(7):4449-56. PubMed ID: 12634405
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]